在手术过程中预测术后肺移植功能障碍:对囊性纤维化患者的单中心队列研究
Pimnara Chuachao1, Jérome Devaquet2, Edouard Sage3
1Department of Epidemiology, Data, Biostatistics, Delegation of Clinical Research and Innovation, Hôpital Foch, Suresnes, France.
Journal of cardiothoracic and vascular anesthesia
|May 25, 2025
概括
在囊性纤维化 (CF) 患者的肺移植后预测严重的初级移植功能障碍 (PGD3) 是可能使用手术内数据. 增加乳酸和体外膜氧化 (ECMO) 使用显著增加PGD3风险.
科学领域:
- 胸部外科手术 胸部外科手术
- 移植免疫学 移植免疫学
- 肺部医学 肺部医学
背景情况:
- 主要移植功能障碍 (PGD3) 是肺移植后的一个主要并发症,特别是在囊性纤维化 (CF) 患者中.
- 使用手术内数据准确预测PGD3可以指导临床管理并改善结果.
研究的目的:
- 在CF患者进行双肺移植后开发和验证严重PGD3 (PGD3) 的预测模型.
- 确定与PGD3风险相关的关键手术内变量.
主要方法:
- 对经过双肺移植 (2012-2019) 的CF患者进行了回顾性单中心队列研究.
- 后勤回归模型是使用9个时间点记录的69个手术内变量来开发的.
- 用曲线下的面积 (AUC) 评估模型性能.
主要成果:
- PGD3发生在15.5%的患者中.
- 预测模型的AUC在手术期间逐渐改善,达到0.892.2.
- 增加PGD3风险的关键预测因素包括第二次肺动脉紧时的乳酸水平和手术结束时体外膜氧化 (ECMO) 的使用.
结论:
- 结合手术内数据的预测模型可以有效预测CF肺移植患者的PGD3风险.
- 持续使用ECMO和高的手术内乳酸水平是PGD3.3的重要危险因素.
- 这种模型可以帮助识别高风险患者并优化术后护理.
更多相关视频
09:54Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
Published on: August 15, 2022
1.9K
10:01Development of Obliterative Bronchiolitis in a Murine Model of Orthotopic Lung Transplantation
Published on: July 10, 2012
20.6K
相关概念视频
Cystic Fibrosis: Management
229
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
229
Cystic Fibrosis: Pathogenesis
378
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
378
